Mehraboon Irani of Nirmal Bang Securities told CNBC-TV18, "We are looking at some of the decent midcap names where we do not see any downside. We are looking at names like Firstsource Solutions, Polaris Financial Technology, and in pharma we like Sun Pharma Advanced Research Company a lot where we have a target of over Rs 300 for the stock in the next two years."
"We also like Tata Motors and Motherson Sumi Systems only for simple reason that they are pure global companies," he adds.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
